SensiScreen® FFPE

SensiScreen® FFPE qPCR Assays enable sensitive detection of somatic mutations in solid cancer biopsies. Using PentaBase’s unique INA® technology, they offer high sensitivity and consistent protocols across all assays. Designed for open platforms, they are available in Ready-to-Use or Dispense Ready formats to suit different workflow needs.

   SensiScreen® FFPE EGFR qPCR Assay, CE-IVD           
   SensiScreen® FFPE BRAF qPCR Assay, CE-IVD           
   SensiScreen® FFPE KRAS qPCR Assay, CE-IVD          
   SensiScreen® FFPE NRAS qPCR Assay, CE-IVD         
   SensiScreen® FFPE KIT qPCR Assay, CE-IVD               
Product Flyer
Order

Our range of Instruments and Extraction Kits

SensiScreen® FFPE EGFR qPCR Assay, CE-IVD
Somatic cancer mutations
SensiScreen® FFPE BRAF qPCR Assay, CE-IVD
Somatic cancer mutations
SensiScreen® FFPE KRAS qPCR Assay, CE-IVD
Somatic cancer mutations
SensiScreen® FFPE NRAS qPCR Assay, CE-IVD
Somatic cancer mutations
SensiScreen® FFPE KIT qPCR Assay, CE-IVD
Somatic cancer mutations

Get in touch

hbspt.forms.create({ region: “na1”, portalId: “6284543”, formId: “213000bd-9df7-4759-bf17-b76f4bbd8de0” });